Matriz de recomendações para farmacoterapia da osteoporose e da osteoartrite: recurso para subsidiar a adaptação de guias de prática clínica

Abstract

WAINBERG, S.K. Matrix of recommendations for osteoporosis and osteoarthritis pharmacotherapy: A resource to subsidize the adaptation process of clinical practice guidelines for the treatment of osteoporosis and osteoarthritis. Dissertação de Mestrado – Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo, 2019. Osteoporosis (OP) and osteoarthritis (OA) are chronic non-communicable diseases (CNCDs), i.e., multifactorial, long-lasting and with age as an aggravating factor. None has cure, and only non-pharmacological and pharmacological treatments to mitigate their effects. In order to support health professionals in terms of the best treatments for both diseases, Clinical Practice Guidelines (CPG) contains recommendations that must be elaborated with high methodological rigor, requiring time, financial support and multiprofessional team. An option is to adapt existing CPG that have been rigorously developed. This study aimed to create a matrix of recommendations based on high quality CPG. The ADAPTE process was used, but only the first two phases: Configuration and Adaptation. The Configuration phase was planned and registered by the Chronic Diseases and Informed Decisions group (CHRONIDE), Brazil, in PROSPERO. For the Adaptation phase, a systematic search was performed using the following eligibility criteria: documents that contained recommendations for the pharmacological treatment of OP and OA in primary care, published in Portuguese, Spanish or English, from 01/01/2011 to 12/31/2016, all stages of the processes were assessed by three independent reviewers. 43 CPG OP and 23 CPG of OA were retrieved and had their quality assessed by the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument. Only ten CPG for OP treatment, and seven GPC for OA treatment were considered high quality and had their recommendations extracted and synthesized in two separate matrices. Biphosphonates were the most suggested pharmacological treatment for OP and non-steroidal anti-inflammatory drugs (NSAIDs), especially acetaminophen, for OA. Findings also showed that the majority of CPG had limitations, mainly regarding their quality, implementation, multiprofessional team, as weel as patients, and editorial independence, indicating the need for improvement. However, the findings made it possible to create two matrices to support future elaboration of local protocols and patient care.